학술논문

ARO-APOC3, an Investigational RNAi Therapeutic, Silences APOC3 and Reduces Atherosclerosis- Associated Lipoproteins in Patients With Mixed Dyslipidemia: MUIR Study Results
Document Type
Journal
Source
CIRCULATION; NOV 7 2023, 148 3p. Supplement: 1
Subject
Language
English
ISSN
15244539